[Efficacy and tolerability of paroxetine in the treatment of the depressive phase of bipolar disorders]. / La paroxetina nel disturbo bipolare in fase depressiva.
Minerva Psichiatr
; 37(2): 91-7, 1996 Jun.
Article
en It
| MEDLINE
| ID: mdl-8926862
Eighty patients aged between 20-65 years and suffering from bipolar disease according to DSM IV criteria, were treated with paroxetine for os at the single dosage of 20-40 mg/die. At regular intervals psychometric reagents were administered for the evaluation and the variations in the bipolar disease. Tolerability was excellent and side-effects mild, with a tendency to regress after the second week of therapy. The clinical assessment and the psychometric findings both suggest that paroxetina has a useful action on the bipolar disease.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Trastorno Bipolar
/
Paroxetina
/
Antidepresivos
Tipo de estudio:
Diagnostic_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
It
Revista:
Minerva Psichiatr
Año:
1996
Tipo del documento:
Article